DNA testing can help right racial imbalance in breast cancer
Study suggests routine genomic testing could correct well-established disparities in breast cancer survival rates between white and Black women.
Newsletters and Deep Dive digital magazine
Study suggests routine genomic testing could correct well-established disparities in breast cancer survival rates between white and Black women.
Blackstone has closed its latest fund – the $6.3bn BXLS VI – saying it is the largest ever private fund for the life sciences sector.
Amgen's fast-growing bispecific T-cell engager Imdylltra should be cleared as a second-line therapy for small cell lung cancer, said the CHMP.
A machine learning algorithm could serve as a pre-screen for hepatocellular carcinoma that identifies patients missed by current narrow guidance.
Corcept shares surge on FDA approval of Lifyorli, a first-in-class selective glucocorticoid receptor antagonist for ovarian cancer.
Editor's Picks
Newsletters and Deep Dive
digital magazine